# OnCo record pierre-fabre (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pierre-fabre/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pierre-fabre" ;
  schema:name "Pierre Fabre"@en ;
  schema:description "Pierre Fabre is a French pharmaceutical and dermo-cosmetics group whose oncology franchise includes vinorelbine (Navelbine), vinflunine (Javlor) and the BRAF/MEK pair encorafenib and binimetinib in Europe."@en ;
  schema:url <https://onco.cc/companies/pierre-fabre/>, <https://www.pierre-fabre.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.pierre-fabre.com> ;
  schema:addressCountry "FR" ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/mek/> ;
  onco:drugs <https://onco.cc/drugs/vinorelbine/>, <https://onco.cc/drugs/vinflunine/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/binimetinib/>, <https://onco.cc/drugs/busulfan/>, <https://onco.cc/drugs/propranolol-hemangeol/>, <https://onco.cc/drugs/tabelecleucel/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/nct06043817/>, <https://onco.cc/trials/nct06567015/>, <https://onco.cc/trials/nct06669117/>, <https://onco.cc/trials/nct04554914/>, <https://onco.cc/trials/nct05270044/>, <https://onco.cc/trials/nct05195632/> .